Net Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2025

Schedule of Computation of Loss Per Share

The following table sets forth the computations of loss per share (in thousands, except share and per share amounts):


	Three Months Ended March 31,
	2025		2024

Numerator:
Net Loss	$	(25,848)	$	(96,130)

Preferred stock dividends and accretion	(1,438)		(1,375)
Net loss attributable to common stockholders	$	(27,286)	$	(97,505)
Denominator:
Weighted–average common shares outstanding, basic and diluted	28,220,936		28,917,897
Net loss per common share, basic and diluted	$	(0.97)	$	(3.37)

Schedule of Anti–dilutive Common Share Equivalents

Potential shares of common stock are excluded from the computation of diluted earnings per share when their effect would be antidilutive. Performance-based restricted stock units are considered dilutive when the related performance criteria have been met assuming the end of the reporting period represents the end of the performance period. All potential shares of common stock are antidilutive in periods of net loss. Potential shares of common stock not included in the computation of earnings per share because their effect would have been antidilutive or because the performance criterion was not met were as follows (in thousands):


	March 31,
	2025	2024

Stock options	103,561	141,699

Restricted stock units	2,679,178	2,937,337
Performance restricted stock units	350,000	350,000
Series A Preferred Stock on an if-converted basis(1)	7,384,195	7,061,046
Total anti–dilutive common share equivalents	10,516,934	10,490,082

(1) As of March 31, 2025, the Series A Preferred Stock plus accumulated dividends totaled $129.2 million. The Series A Preferred Stock has a conversion price of $17.50 per share, as detailed in “Note 9. Mezzanine Equity”.